Inaugural Miami Cancer Institute Summit of the Americas on Immunotherapies for Hematologic Malignancies

Coral Gables, FL US
January 24, 2020 to January 25, 2020

Given the increasing frequency of hematologic malignancies, complexities of treatments with novel agents and particularly with immunotherapeutic approaches, there is a need to provide an opportunity for oncologists, hematologists, oncology nurses and pharmacists to engage in a thoughtful discussions with experts in these fields. In addition, there is emerging data about the biology of these malignancies impacting optimal management of patients with these disorders. Clinical decision making and management therefore has become more complex.

This one-and-a-half-day symposium has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of leukemia, lymphoma, multiple myeloma and stem cell transplantation by novel immunotherapies and treatment combinations. Updates on evolving immunologically and molecular based system therapies will be profiled and discussed.
 

Complete details at  MiamiCancerInstitute.com/HematologicMalignancies

Registration Fees

 PhysiciansBaptist Health EmployeesOther Healthcare ProfessionalsFellows and StudentsInternational PhysiciansInternational Other
Early Bird (Before December 2, 2019)                         $325$55$165$95$228$116
Registration after December 2, 2019$450$75$215$125$315$150

Target Audience

This educational program is directed toward hematologists, oncologists, pathologists, radiation oncologists, palliative care staff, medical oncology, hematology nurses, pharmacists and other allied health care professionals interested in the treatment of patients with hematologic malignancies.

Learning Objectives

  • Summarize the evolving therapeutic strategies in the treatment of hematologic malignancies.
  • Provide an update of new molecular and immunological treatments being developed for these diseases.
  • Discuss the rationale for new targeted diagnostic and therapeutic strategies for lymphoma, myeloma and leukemia.
  • Review the role and timing of hematopoietic cell transplantation and potential combinations of immunotherapeutic treatment options.
Course summary
Available credit: 
  • 9.50 AMA PRA Category 1 Credit™
  • 9.50 General certificate of attendance
Course opens: 
06/07/2019
Course expires: 
03/28/2020
Event starts: 
01/24/2020 - 8:45am
Event ends: 
01/25/2020 - 1:00pm
Cost:
$325.00
Rating: 
0
The Ritz Carlton Coconut Grove
3300 Southwest 27th Avenue
Coral Gables, FL 33133
United States
+1 (305) 644-4680

​First settled in 1825, Coconut Grove has attracted travelers and artists for centuries with its welcoming climate and vibrant cultural amenities. Begin your artful journey of this eclectic neighborhood at The Ritz-Carlton Coconut Grove with its own deep hues of creative expression.

Set on four acres of lushly-landscaped gardens in the heart of Coconut Grove, The Ritz-Carlton is also just minutes from first-class shopping, exciting night life, fine restaurants, area attractions and iconic beaches drawing visitors into this quintessential Miami experience. 

For additional tourist information, including a host of annual art festivals and events, please visit miamiandbeaches.com​.

Directors 
Guenther Koehne, M.D., Ph.D.  

Co-Directors
Robert Sackstein, M.D., Ph.D. and Marcel van den Brink, M.D., Ph.D.

Faculty 

Adam D. Cohen, M.D.
Assistant Professor, Medicine
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania

Nitin Jain, M.D. 
Associate Professor of Medicine
Department of Leukemia
MD Anderson Cancer Center
Houston, Texas

Guenther Koehne M.D., Ph.D.
Deputy Director of Miami Cancer Institute
Chief of Blood & Marrow Transplant and Hematologic Oncology
Miami Cancer Institute  
Miami, Florida

Ola Landgren, M.D., Ph.D. 
Professor of Medicine 
Chief, Myeloma Service 
Department of Medicine 
Memorial Sloan Kettering Cancer Center
New York, New York

Richard O’Reilly, M.D. 
Claire L. Tow Chair in Pediatric Oncology Research
Attending Physician 
Memorial Sloan Kettering
New York, New York

Susan E. Prockop, M.D. 
Pediatric Oncology; Allogeneic and Autologous Bone Marrow and
Peripheral Blood Stem Cell Transplantation
Congenital and Acquired Diseases of Hematopoiesis and Immunity
Memorial Sloan Kettering
New York, New York

Katy Rezvani, M.D. 
Professor of Medicine
Chief of Section of Cellular Therapy
MD Anderson
Houston, Texas

Paul G. Richardson, M.D. 
Medical Oncologist
Dana-Farber Cancer Institute
Boston, Massachusetts 

Robert Sackstein, M.D., PhD. 
Interim Chair, Department of Translational Medicine 
Dean and Senior Vice President for Health Affairs, and Professor
Florida International University
Miami, Florida

Michel W. Saldelain, M.D., Ph.D. 
Director Center for Cell Engineering
Memorial Sloan Kettering 
New York, New York

Elizabeth J. Shpall, M.D. 
Cancer Center Support Grant Programs
Stem Cell Transplantation
Brain Cancer
MD Anderson Cancer Center
Houston, Texas

Robert Soiffer, M.D. 
Professor of Medicine
Harvard Medical School 
Chief - Division of Hematologic Malignancies 
Brigham and Women’s Hospital 
Boston, Massachusetts

Eytan M. Stein, M.D.
Hematologic Oncologist
Memorial Sloan Kettering
New York, New York

Wendy Stock, M.D. 
Anjuli Seth Nayak Professor of Medicine, 
Section of Hematology/Oncology
University of Chicago
Chicago, Illinois

Marty Tallman, M.D. 
Chief, Leukemia Service
Memorial Sloan Kettering
Professor of Medicine
Weil Cornell Medical College
New York, New York

Marcel R.M. van den Brink, M.D., Ph.D. 
Head, Division of Hematologic Malignancies
Memorial Sloan Kettering Cancer Center 
New York,  New York 

Anas Younes, M.D. 
Chief Lymphoma Service
Memorial Sloan Kettering
New York, New York

 

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant relationships with commercial interest companies. 

 

Disclosure Policy and Disclaimer

Information will be available soon.  Please visit us at a later time.

Available Credit

  • 9.50 AMA PRA Category 1 Credit™
  • 9.50 General certificate of attendance

Accreditation Period

Course opens: 
06/07/2019
Course expires: 
03/28/2020

Price

Cost:
$325.00
Please login or register to take this course.

Registration Fees

 PhysiciansBaptist Health EmployeesOther Healthcare ProfessionalsFellows and Students
Early Bird (Before December 2, 2019)$325$55$165$95
Registration after December 2, 2019$450$75$215$125

 

Cancelation Policy
Changes may occur that are beyond our control. In the unforeseen event the symposium is canceled, Baptist Health will refund attendees the entire amount of their registration fees. If you are traveling from outside of the area, we strongly suggest purchasing travel insurance. 

Cancelations must be received by January 9, 2020  to receive a refund of the registration fee, less a $25 administrative fee. Registration fees are not refundable after January 9, 2020. ​
 

Required Hardware/software

If you are not able to register, please look in the upper right to see if there is something in your shopping cart.

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.

Technical Support